Cargando…

Prevalence of obesity and its association with cardiometabolic risk factors, heart failure phenotype and mortality among patients hospitalized for heart failure in Egypt

BACKGROUND: Obesity is an established risk factor for cardiometabolic disease and heart failure (HF). Nevertheless, the relationship between obesity and HF mortality remains controversial. RESULTS: The goal of this study was to describe the prevalence of obesity in patients hospitalized for HF in Eg...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassanin, Ahmed, Hassanein, Mahmoud, Lanier, Gregg M., Sadaka, Mohamed, Rifaat, Mohamed, Sanhoury, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724509/
https://www.ncbi.nlm.nih.gov/pubmed/34978627
http://dx.doi.org/10.1186/s43044-021-00232-y
_version_ 1784625913094209536
author Hassanin, Ahmed
Hassanein, Mahmoud
Lanier, Gregg M.
Sadaka, Mohamed
Rifaat, Mohamed
Sanhoury, Mohamed
author_facet Hassanin, Ahmed
Hassanein, Mahmoud
Lanier, Gregg M.
Sadaka, Mohamed
Rifaat, Mohamed
Sanhoury, Mohamed
author_sort Hassanin, Ahmed
collection PubMed
description BACKGROUND: Obesity is an established risk factor for cardiometabolic disease and heart failure (HF). Nevertheless, the relationship between obesity and HF mortality remains controversial. RESULTS: The goal of this study was to describe the prevalence of obesity in patients hospitalized for HF in Egypt and investigate the relationship of obesity to cardiometabolic risk factors, HF phenotype and mortality. Between 2011 and 2014, 1661 patients hospitalized for HF across Egypt were enrolled as part of the European Society of Cardiology HF Long-term Registry. Obese patients, defined by a BMI ≥ 30 kg/m(2), were compared to non-obese patients. Factors associated with mortality on univariate analysis were entered into a logistic regression model to identify whether obesity was an independent predictor of mortality during hospitalization and at one-year follow-up. The prevalence of obesity was 46.5% and was higher in females compared to males. Obese as compared to non-obese patients had a higher prevalence of diabetes mellitus (47.0% vs 40.2%, p = 0.031), hypertension (51.3% vs 33.0%, p < 0.001) and history of myocardial infarction (69.2% vs 62.8% p = 0.005). Obese patients as compared to non-obese patient were more likely to have acute coronary syndrome on admission (24.8% vs 14.2%, p <  < 0.001). The dominant HF phenotype in obese and non-obese patients was HF with reduced ejection fraction (EF); however, obese patients as compared to non-obese patient had higher prevalence of HF with preserved EF (22.3% vs 12.4%, p < 0.001). Multivariable analysis demonstrated that obesity was associated with an independent survival benefit during hospitalization, (OR for mortality 0.52 [95% CI 0.29–0.92]). Every point increase in BMI was associated with an OR = 0.93 [95% CI 0.89–0.98] for mortality during hospitalization. The survival benefit was not maintained at one-year follow-up. CONCLUSIONS: Obesity was highly prevalent among the study cohort and was associated with higher prevalence of cardiometabolic risk factors as compared to non-obese patients. Obesity was associated with an independent “protective effect” from in-hospital mortality but was not a predictor of mortality at 1-year follow-up.
format Online
Article
Text
id pubmed-8724509
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-87245092022-01-14 Prevalence of obesity and its association with cardiometabolic risk factors, heart failure phenotype and mortality among patients hospitalized for heart failure in Egypt Hassanin, Ahmed Hassanein, Mahmoud Lanier, Gregg M. Sadaka, Mohamed Rifaat, Mohamed Sanhoury, Mohamed Egypt Heart J Research BACKGROUND: Obesity is an established risk factor for cardiometabolic disease and heart failure (HF). Nevertheless, the relationship between obesity and HF mortality remains controversial. RESULTS: The goal of this study was to describe the prevalence of obesity in patients hospitalized for HF in Egypt and investigate the relationship of obesity to cardiometabolic risk factors, HF phenotype and mortality. Between 2011 and 2014, 1661 patients hospitalized for HF across Egypt were enrolled as part of the European Society of Cardiology HF Long-term Registry. Obese patients, defined by a BMI ≥ 30 kg/m(2), were compared to non-obese patients. Factors associated with mortality on univariate analysis were entered into a logistic regression model to identify whether obesity was an independent predictor of mortality during hospitalization and at one-year follow-up. The prevalence of obesity was 46.5% and was higher in females compared to males. Obese as compared to non-obese patients had a higher prevalence of diabetes mellitus (47.0% vs 40.2%, p = 0.031), hypertension (51.3% vs 33.0%, p < 0.001) and history of myocardial infarction (69.2% vs 62.8% p = 0.005). Obese patients as compared to non-obese patient were more likely to have acute coronary syndrome on admission (24.8% vs 14.2%, p <  < 0.001). The dominant HF phenotype in obese and non-obese patients was HF with reduced ejection fraction (EF); however, obese patients as compared to non-obese patient had higher prevalence of HF with preserved EF (22.3% vs 12.4%, p < 0.001). Multivariable analysis demonstrated that obesity was associated with an independent survival benefit during hospitalization, (OR for mortality 0.52 [95% CI 0.29–0.92]). Every point increase in BMI was associated with an OR = 0.93 [95% CI 0.89–0.98] for mortality during hospitalization. The survival benefit was not maintained at one-year follow-up. CONCLUSIONS: Obesity was highly prevalent among the study cohort and was associated with higher prevalence of cardiometabolic risk factors as compared to non-obese patients. Obesity was associated with an independent “protective effect” from in-hospital mortality but was not a predictor of mortality at 1-year follow-up. Springer Berlin Heidelberg 2022-01-03 /pmc/articles/PMC8724509/ /pubmed/34978627 http://dx.doi.org/10.1186/s43044-021-00232-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Hassanin, Ahmed
Hassanein, Mahmoud
Lanier, Gregg M.
Sadaka, Mohamed
Rifaat, Mohamed
Sanhoury, Mohamed
Prevalence of obesity and its association with cardiometabolic risk factors, heart failure phenotype and mortality among patients hospitalized for heart failure in Egypt
title Prevalence of obesity and its association with cardiometabolic risk factors, heart failure phenotype and mortality among patients hospitalized for heart failure in Egypt
title_full Prevalence of obesity and its association with cardiometabolic risk factors, heart failure phenotype and mortality among patients hospitalized for heart failure in Egypt
title_fullStr Prevalence of obesity and its association with cardiometabolic risk factors, heart failure phenotype and mortality among patients hospitalized for heart failure in Egypt
title_full_unstemmed Prevalence of obesity and its association with cardiometabolic risk factors, heart failure phenotype and mortality among patients hospitalized for heart failure in Egypt
title_short Prevalence of obesity and its association with cardiometabolic risk factors, heart failure phenotype and mortality among patients hospitalized for heart failure in Egypt
title_sort prevalence of obesity and its association with cardiometabolic risk factors, heart failure phenotype and mortality among patients hospitalized for heart failure in egypt
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724509/
https://www.ncbi.nlm.nih.gov/pubmed/34978627
http://dx.doi.org/10.1186/s43044-021-00232-y
work_keys_str_mv AT hassaninahmed prevalenceofobesityanditsassociationwithcardiometabolicriskfactorsheartfailurephenotypeandmortalityamongpatientshospitalizedforheartfailureinegypt
AT hassaneinmahmoud prevalenceofobesityanditsassociationwithcardiometabolicriskfactorsheartfailurephenotypeandmortalityamongpatientshospitalizedforheartfailureinegypt
AT laniergreggm prevalenceofobesityanditsassociationwithcardiometabolicriskfactorsheartfailurephenotypeandmortalityamongpatientshospitalizedforheartfailureinegypt
AT sadakamohamed prevalenceofobesityanditsassociationwithcardiometabolicriskfactorsheartfailurephenotypeandmortalityamongpatientshospitalizedforheartfailureinegypt
AT rifaatmohamed prevalenceofobesityanditsassociationwithcardiometabolicriskfactorsheartfailurephenotypeandmortalityamongpatientshospitalizedforheartfailureinegypt
AT sanhourymohamed prevalenceofobesityanditsassociationwithcardiometabolicriskfactorsheartfailurephenotypeandmortalityamongpatientshospitalizedforheartfailureinegypt